<HashMap><database>biostudies-other</database><scores/><additional><submitter>Wang L</submitter><pagination>2035</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-ECPF-GEOD-46632</full_dataset_link><project>EurocanPlatform</project><abstract>JIB-04 is an inhibitor of Jumonji histone demethylases identified through a cell based screen that measures the reactivation of an epigenetically silenced transgene. The active JIB-04 E-isomer shows selectivity for cancer vs. normal cells affecting both transcriptional patterns and cell viability in a cancer specific manner. H358 lung cancer cells or the patient matched HCC4017 (cancer) vs. HBEC30KT (immortalized normal) lung cell pair were treated with DMSO vehicle or 500nM E-isomer or 500 nM Z-isomer of JIB-04 for 4 h or 24 h and RNA extracted.</abstract><repository>biostudies-other</repository><experiment_type>transcription profiling by array</experiment_type><data_source>EurocanPlatform</data_source><omics_type>Unknown</omics_type><volume>4</volume><journal>Nature communications</journal><species>Homo sapiens</species><pubmed_authors>Easmon J</pubmed_authors><pubmed_authors>Quinn AM</pubmed_authors><pubmed_authors>Brekken RA</pubmed_authors><pubmed_authors>Martinez ED</pubmed_authors><pubmed_authors>Peña-Llopis S</pubmed_authors><pubmed_authors>Frantz DE</pubmed_authors><pubmed_authors>Babinski DJ</pubmed_authors><pubmed_authors>Varghese D</pubmed_authors><pubmed_authors>Dellinger M</pubmed_authors><pubmed_authors>Xu J</pubmed_authors><pubmed_authors>Wang L</pubmed_authors><pubmed_authors>Kumar S</pubmed_authors><pubmed_authors>Bruick R</pubmed_authors><pubmed_authors>Ruiz J</pubmed_authors><pubmed_authors>Best AM</pubmed_authors><pubmed_authors>Simeonov A</pubmed_authors><pubmed_authors>Chang J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of genes modulated by JIB-04 in lung cancer cells</name><description>JIB-04 is an inhibitor of Jumonji histone demethylases identified through a cell based screen that measures the reactivation of an epigenetically silenced transgene. The active JIB-04 E-isomer shows selectivity for cancer vs. normal cells affecting both transcriptional patterns and cell viability in a cancer specific manner. H358 lung cancer cells or the patient matched HCC4017 (cancer) vs. HBEC30KT (immortalized normal) lung cell pair were treated with DMSO vehicle or 500nM E-isomer or 500 nM Z-isomer of JIB-04 for 4 h or 24 h and RNA extracted.</description><dates><release>2016-04-14T14:24:13Z</release><publication>2013</publication><modification>2016-04-14T14:24:13Z</modification><creation>2016-04-14T14:24:13Z</creation></dates><accession>S-ECPF-GEOD-46632</accession><cross_references><GEO>GSE46632</GEO><ArrayExpress>E-GEOD-46632</ArrayExpress><EFO>EFO_0000322</EFO><EFO>EFO_0001071</EFO><ArrayExpress files>E-GEOD-46632</ArrayExpress files></cross_references></HashMap>